2009
DOI: 10.4084/mjhid.2009.028
|View full text |Cite
|
Sign up to set email alerts
|

Infections in Thalassemia and Hemoglobinopathies

Abstract: The clinical approach to thalassemia and hemoglobinopathies, specifically Sickle Cell Disease (SCD), based on transfusions, iron chelation and bone marrow transplantation has ameliorated their prognosis. Nevertheless, infections still may cause serious complications in these patients. The susceptibility to infections in thalassemia and SCD arises both from a large spectrum of immunological abnormalities and from exposure to specific infectious agents. Four fundamental issues will be focused upon as central cau… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
53
0
6

Year Published

2011
2011
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 51 publications
(63 citation statements)
references
References 116 publications
(117 reference statements)
1
53
0
6
Order By: Relevance
“…Interestingly, patients with transfusional iron overload, as well as those with hereditary forms of hemochromatosis, may have circulating non-transferrin-bound iron levels 25,26 similar to those measured in our healthy volunteers at 4 hours after transfusion with older RBCs and are known to be at an increased risk for acute and chronic infections with specific pathogens. [27][28][29] In addition, oral iron supplements are associated with transient increases in non-transferrin-bound iron, 19,30 and routine supplementation with iron and folic acid in children in a malaria-endemic region increased the risk of severe illness and death. 31,32 An incidental finding from this study is the extent of variability in hemoglobin levels measured soon after transfusion ( Figure 1B-C), with 6 of 14 volunteers exhibiting either a decrease or no increase in hemoglobin at 4 hours after transfusion of fresh autologous RBCs.…”
mentioning
confidence: 99%
“…Interestingly, patients with transfusional iron overload, as well as those with hereditary forms of hemochromatosis, may have circulating non-transferrin-bound iron levels 25,26 similar to those measured in our healthy volunteers at 4 hours after transfusion with older RBCs and are known to be at an increased risk for acute and chronic infections with specific pathogens. [27][28][29] In addition, oral iron supplements are associated with transient increases in non-transferrin-bound iron, 19,30 and routine supplementation with iron and folic acid in children in a malaria-endemic region increased the risk of severe illness and death. 31,32 An incidental finding from this study is the extent of variability in hemoglobin levels measured soon after transfusion ( Figure 1B-C), with 6 of 14 volunteers exhibiting either a decrease or no increase in hemoglobin at 4 hours after transfusion of fresh autologous RBCs.…”
mentioning
confidence: 99%
“…Eritropoietik inefektif dan hemolisis menyebabkan monosit/makrofag menjadi hiperplasia dan hiperaktif memfagositosis prekursor eritrosit yang rusak dan juga eritrosit matur. 9 Anemia yang berat pada pasien talasemia, juga merupakan faktor risiko terjadinya infeksi. 17 Pemberian transfusi darah berulang berhubungan dengan stimulasi aloantigenik terus menerus dan juga berhubungan dengan hemolisis autoimun.…”
Section: Respons Imun Pada Talasemiaunclassified
“…18 Limpa berperan penting dalam respons imun karena limpa merupakan sumber penting limfosit imunokompeten. 9 Limpa dan kelenjar getah bening merupakan tempat sel dendritik mempresentasikan antigen yang ditangkap di bagian lain tubuh ke sel T yang memacunya untuk proliferasi dan diferensiasi limfosit. 22 Secara umum, limpa berfungsi untuk memfiltrasi antigen dan mikroorganisme dan juga berfungsi dalam proses sintesis antibodi dan komplemen.…”
Section: Seng Dan Respons Imununclassified
See 1 more Smart Citation
“…Severe anaemia, iron overload, splenectomy, and a range of other immune abnormalities can be considered as some of the risk factors causing infections in these patients [3,4]. Infections are considered as the second most common cause of morbidity in thalassemia patients [4].…”
Section: Alpha (α) or Beta (β) Thalassemia Traitmentioning
confidence: 99%